Brivanext 25 Tablet

Brivanext 25 Tablet contains Brivaracetam 25 mg tablet. Prescription required.

Treatment of partial-onset (focal) seizures in epilepsy, as monotherapy or adjunctive therapy (as prescribed).

Brivaracetam is an antiepileptic that binds selectively to synaptic vesicle protein 2A (SV2A) in the brain. This modulates neurotransmitter release and helps stabilize abnormal electrical activity, reducing seizure frequency.

Tablet for oral use. Take exactly as prescribed, usually twice daily, with or without food; swallow whole with water. Do not stop abruptly without medical advice.

Drowsiness, dizziness, fatigue, nausea, vomiting, irritability, somnolence

May cause sleepiness, dizziness and impair driving/operating machinery. Risk of mood/behavior changes (irritability, depression, suicidal thoughts); seek medical help if these occur. Use with caution in liver impairment (dose adjustment may be needed). Do not discontinue suddenly due to risk of increased seizures; taper as advised.

Rifampicin (may reduce brivaracetam levels), carbamazepine (may increase carbamazepine-epoxide), phenytoin (levels may increase at higher brivaracetam doses), alcohol and other CNS depressants (additive sedation).

Store below 25°C in a dry place, protected from light and moisture. Keep out of reach of children.

Briviact 25 Tablet, Brivarap 25 Tablet, Brivz 25 Tablet, Brivakind 25 Tablet, Brivam 25 Tablet